Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Global Summit on Stroke

Birmingham, UK

Nany Elgayar

Nany Elgayar

Alexandria University, Egypt

Title: Evaluation of the role of ischemia modifi ed albumin as a new biochemical marker for differentiation between ischemic and hemorrhagic stroke


Biography: Nany Elgayar


Objective: To evaluate the role of the detection of ischemia modifi ed albumin (IMA) level in the diff erentiation between ischemic and hemorrhagic cerebrovascular stroke. Materials & Methods: Sixty elderly persons classifi ed into three groups, 25 patients diagnosed with cerebral infarction, 15 patients diagnosed with cerebral hemorrhage and 20 elderly healthy persons with matched age as control were enrolled in the study. IMA was measured using the available chemical method and computerized tomography (CT) was done for diagnosis of brain lesions. Results: IMA was signifi cantly higher in patient group than control group. Th ere was positive signifi cant correlation between age, albumin with IMA, (P=0.000 and 0.037 respectively). However there was no statistical signifi cant diff erence between sex and diagnosis cross tabulation (0.51). It was found that, IMA was statistically higher in infarction group than hemorrhage group (P=0.000) and IMD index was statistically higher in infarction group than hemorrhage group (P=0.013). Our investigation in elderly patients suggests that IMA assay is a sensitive marker for early detection ischemic and hemorrhagic stroke.

Speaker Presentations

Speaker PPTs Click Here